SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigDaddyMac who wrote (631)6/15/1998 8:47:00 AM
From: drdan   of 5402
 
Mitch, you are quite right that this will not happe overnight. However, that does not mean that tis company is not a resonable investment risk now or in the near future. Please remember that large pharmaceutical firms do not wait until Phase 3 human testing is done before they back a reserch company. all these companies need to see is a bit of data suggestive of success. Look at somatogen recently. Look at Alliance before J&J scaled back their financing. They got money for their product and they are not even close to being on the market. Folks you wont have a dead money stock, here. It will sink or swim in a short period of time -weeks to months, IMO. Mitch, your concern is appreciated but your comment is a bit exaggerated and perhaps not entirely relevant. BTW< are the deaths you refer to from the Jehovah's Witnesses testing? Have a good day.....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News